Eastland Medical Systems Ltd.
www.eastlandmedical.com.au

Eastland was incorporated in 1999 and since listing on the Australian Stock Exchange (ASX) in January 2002 has evolved from a ‘start up' technology company to become a vertically-integrated developer, manufacturer and distributor of safe injectable devices and other established medical products.

  

back to top

Of its initial six patented products four have been fully developed, functionally tested and have clearly identified target markets. These products are “Clip-On”, “Safeline”, “AutoInjecta” and “Reversyringe”. These retractable needle devices deliver improved safety and functionality at a cost comparable with current industry standard products. 2004 will see a range of these devices introduced to the market

Eastland has also significantly added to the value of its intellectual property portfolio with the patenting and development of “Precision Angular Presentation” (PAP) needle grinding technology which also has far reaching applications outside the medical industry.

Furthermore, development has been completed on two new mass vaccination devices, and a range of retractable coring needles with medical, vetinary and aquaculture applications.

In 2003 EMS acquired two Australian based companies; Portland Surgical Products ( Portland ) and Medical Industries Australia (MIA).

back to top

Portland has enabled EMS not only to secure the supply of high quality speciality needles required for its safe devices but also provided the organisational capabilities and physical resources to fast-track the ongoing successful commercialisation of technology.

Medical Industries Australia provides EMS with an experienced, sales, marketing and distribution organisation. Over the past fourteen years MIA has seen continued profitable growth and becomes a well respected distributor to the Australian Healthcare market. MIA is responsible for marketing and distributing the EMS technology and product portfolio throughout the Australian, Asian, Japanese, Pacific and African Markets.

In November 2003 Eastland Medical Systems PLC was created. This UK based company is responsible for marketing and distributing the EMS technology and product portfolio throughout the European, American and Middle Eastern Markets.

back to top
 
 

Eastland Medical Systems SA (Pty) Ltd.

Eastland Medical Systems SA Pty Ltd (“EMSSA”) was incorporated as a South African Corporation, in November 2004 for the purpose of acquiring the South African needleand syringe manufacturer, patents and intellectual property that cover a range of products that utilize new technology for injection, infusion and blood drawing devices, designed to protect health care workers from needlestick injury for the territories of Sub-Saharan Africa.

 

back to top

The patents acquired by EMSSA from Eastland Medical Systems Ltd (“ EMS ”), a company listed on the Australian and London stock exchanges, offer an opportunity to establish a significant medical devices company in South Africa, at a time when there is an identifiable need for the company's products.

EMS has also acquired advanced flat-bed needle grinding machines that can produce 56 diffrent types of needles, from dental needles through to speciality needles.

On Instalation and commissioning of these machines EMSSA will be the major needle manufacturer in SADC with full needle range. EMSSA are looking at other medical products with sustainable markets and margins.

back to top

  
 
 

Portland Surgical Products (Pty) Ltd.
www.portlandsurgical.biz

Portland Surgical Products (Pty) Ltd is a proprietary limited company currently involved in the manufacture of specialty needles, surgical products and a wide range of Research and Development programs.

 Portland Surgical Products (Pty) Ltd has a lateral but very effective management organisation comprising around 15 long serving full time and part time employees. In addition PSP has a highly developed and effective network of consultants who are used on a project by project basis.

 

back to top


Portland has developed an extensive range of specialty needles over the past 20 years, providing a range unequalled anywhere in Australia , even perhaps the world. Some of these specialty needles include; Emulsifying, Epidural Anesthesia, Pudendal, Paracervical Nerve Block Needles, Retobulbar, Spinal, Topical, Bone Marrow, Liver and Kidney, Pleural, Synovial, Blood Sampling, Arterial Intravenous & Blood Transfusion, Haemorrhoidal, Discography, Myelography, Sialography, Chest and Cardiac, Lumber Puncture, Airway Needles, St Vincent's Nerve Block and Aspirating Needles.

Portland has also developed a line of thoracic and wound drainage systems, which it has continued to enhance over the years. One of these, the Thora Valve, is a positive relief safety valve incorporated in the Portland Chest Drainage System. In Australia and New Zealand , this product is sold under the brand name of Tyco. There is a substantial market for this product and is secured by patents in most countries.

Portland has also developed a range of Veterinary products that have considerable market potential throughout the world. 

Portland holds a license for the manufacture of sterile therapeutic devices covering the listings of hypodermic needle manufacture, sterile tubes and tubing, drainage devices and breathing circuits and filters. 

Portland Surgical Products provides Australian and overseas hospitals and medical/veterinary suppliers with reliable medical products and Portland leads the market with modern research and development. 

back to top

  
 
 

Medical Industries Australia (Pty) Ltd.
www.medind.com.au

The acquisition of MIA provides Eastland with a profitable, experienced and successful marketing and distribution organization to facilitate access to markets for Eastland's range of safe injectable devices and other products.

Founded in 1982, Medical Industries Australia (MIA) is a significant independent importer, distributor and supplier of medical, therapeutic and allied products.

 

back to top


MIA has an established client base in Government and Private Sector Hospitals, clinics, medical practitioners and pharmacies across Australia. The Administration, Warehousing, Sales and Distribution functions are centered in Sydney, in the State of New South Wales.

In excess of 70% of revenue is generated by MIA's own brands. Owning these key brands underpins MIA's competitive advantage. Innovation, product quality and cost competitiveness combined with the capacity to supply customers “ex-stock” has cemented effective long term customer and supplier relationships.